CVE-2025-62129: Magnigenie Restropress

Medium severity, CVSS 5.3. EPSS: 0.2% chance of exploitation in the next 30 days.

Missing Authorization vulnerability in Magnigenie RestroPress restropress allows Exploiting Incorrectly Configured Access Control Security Levels.This issue affects RestroPress: from n/a through <= 3.2.7.

Affected products

• Magnigenie Restropress: up to and including 3.2.7

Published 2025-12-31. Last modified 2026-06-17.